Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Fecci

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Neuro-Oncology Advances|December 24, 2024
Combination checkpoint blockade and laser interstitial thermal therapy in radiographically progressive non-small cell lung cancer brain metastasesAden P Haskell-Mendoza, Ethan S Srinivasan, Ariel T Gonzalez, et al.
Neurosurgical Review|July 21, 2025
Disparities in clinical trial enrollment related to laser interstitial thermal therapy for central nervous system metastasesAden P Haskell-Mendoza, Ariel T Gonzalez, Ellery H Reason, et al.
Frontiers in Neurology|January 23, 2024
Preoperative validation of edema-corrected tractography in neurosurgical practice: translating surgeon insights into novel software implementationSebastian F Koga, Wesley B Hodges, Hayk Adamyan, et al.
Journal for Immunotherapy of Cancer|March 24, 2026
IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastomaSteven Shen, Aditya A Mohan, Kelly M Hotchkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and OutcomeBalint Otvos, Tyler J Alban, Matthew M Grabowski, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2026
Contemporary Management of Radiation Necrosis: Insights and AvenuesMichelle M Williams, Aden P Haskell-Mendoza, Ethan A Massat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted HostsCarter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Frontiers in Oncology|February 11, 2022
A Need for More Molecular Profiling in Brain MetastasesErica Shen, Amanda E D Van Swearingen, Meghan J Price, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Neuro-Oncology Advances|December 24, 2024
Combination checkpoint blockade and laser interstitial thermal therapy in radiographically progressive non-small cell lung cancer brain metastasesAden P Haskell-Mendoza, Ethan S Srinivasan, Ariel T Gonzalez, et al.
Neurosurgical Review|July 21, 2025
Disparities in clinical trial enrollment related to laser interstitial thermal therapy for central nervous system metastasesAden P Haskell-Mendoza, Ariel T Gonzalez, Ellery H Reason, et al.
Frontiers in Neurology|January 23, 2024
Preoperative validation of edema-corrected tractography in neurosurgical practice: translating surgeon insights into novel software implementationSebastian F Koga, Wesley B Hodges, Hayk Adamyan, et al.
Journal for Immunotherapy of Cancer|March 24, 2026
IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastomaSteven Shen, Aditya A Mohan, Kelly M Hotchkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and OutcomeBalint Otvos, Tyler J Alban, Matthew M Grabowski, et al.
Oncotarget|September 23, 2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumorsYu Mei, Wenya Linda Bi, Noah F Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2026
Contemporary Management of Radiation Necrosis: Insights and AvenuesMichelle M Williams, Aden P Haskell-Mendoza, Ethan A Massat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted HostsCarter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Frontiers in Oncology|February 11, 2022
A Need for More Molecular Profiling in Brain MetastasesErica Shen, Amanda E D Van Swearingen, Meghan J Price, et al.
Pageof 12